Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (1): 23-27.DOI: 10.3969/j.issn.1673-8640.2022.01.004
Previous Articles Next Articles
YU Jianhong, PENG Qingyuan, YIN Minggang()
Received:
2020-03-23
Revised:
2021-02-08
Online:
2022-01-30
Published:
2022-03-07
Contact:
YIN Minggang
CLC Number:
YU Jianhong, PENG Qingyuan, YIN Minggang. Establishment of reference intervals of serum PGⅠ,PGⅡ and PGR for apparently healthy subjects in Zigong[J]. Laboratory Medicine, 2022, 37(1): 23-27.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.01.004
性别 | 例数 | PGⅠ/(ng/mL) | PGⅡ/(ng/mL) | PGR |
---|---|---|---|---|
男性 | 1 804 | 63.20(50.70~77.80) | 14.30(9.70~23.70) | 4.68(2.93~5.87) |
女性 | 1 076 | 50.90(41.43~64.55) | 10.70(7.63~17.20) | 4.92(3.71~5.93) |
Z值 | -6.941 | -5.781 | -2.207 | |
P值 | 0.000 | 0.000 | 0.027 |
性别 | 例数 | PGⅠ/(ng/mL) | PGⅡ/(ng/mL) | PGR |
---|---|---|---|---|
男性 | 1 804 | 63.20(50.70~77.80) | 14.30(9.70~23.70) | 4.68(2.93~5.87) |
女性 | 1 076 | 50.90(41.43~64.55) | 10.70(7.63~17.20) | 4.92(3.71~5.93) |
Z值 | -6.941 | -5.781 | -2.207 | |
P值 | 0.000 | 0.000 | 0.027 |
组别 | 例数 | PGⅠ/(ng/mL) | PGⅡ/(ng/mL) | PGR |
---|---|---|---|---|
18~44岁组 | 1 468 | 52.30(43.00~67.30) | 10.90(7.90~19.20) | 4.94(3.36~5.91) |
45~59岁组 | 1 160 | 63.80(50.78~84.10)* | 14.00(10.00~23.70)* | 4.59(3.09~5.90) |
>59岁组 | 252 | 66.95(56.20~87.88)*# | 15.95(11.48~23.20)*# | 4.70(3.47~5.52) |
H值 | 54.574 | 26.212 | 2.073 | |
P值 | 0.000 | 0.000 | 0.355 |
组别 | 例数 | PGⅠ/(ng/mL) | PGⅡ/(ng/mL) | PGR |
---|---|---|---|---|
18~44岁组 | 1 468 | 52.30(43.00~67.30) | 10.90(7.90~19.20) | 4.94(3.36~5.91) |
45~59岁组 | 1 160 | 63.80(50.78~84.10)* | 14.00(10.00~23.70)* | 4.59(3.09~5.90) |
>59岁组 | 252 | 66.95(56.20~87.88)*# | 15.95(11.48~23.20)*# | 4.70(3.47~5.52) |
H值 | 54.574 | 26.212 | 2.073 | |
P值 | 0.000 | 0.000 | 0.355 |
组别 | 例数 | PGⅠ/(ng/mL) | PGⅡ/(ng/mL) | PGR |
---|---|---|---|---|
18~44岁组 | ||||
男性 | 936 | 57.70(47.08~71.73) | 13.25(9.18~21.43) | 4.83(2.99~5.85) |
女性 | 532 | 43.50(38.35~54.35)△ | 8.50(6.75~14.75)△ | 5.22(3.98~6.08)△ |
45~59岁组 | ||||
男性 | 724 | 67.30(53.75~86.25)* | 15.10(10.30~26.15)* | 4.57(2.71~6.09) |
女性 | 436 | 58.70(47.60~76.35)*△ | 12.10(9.30~20.20)*△ | 4.66(3.56~5.73) |
>59岁组 | ||||
男性 | 144 | 69.60(58.53~94.33)*# | 16.70(13.90~23.85)*# | 4.18(3.46~5.29) |
女性 | 108 | 57.35(51.95~77.20)*# | 11.35(9.80~22.30)*#△ | 4.84(4.21~5.89) |
组别 | 例数 | PGⅠ/(ng/mL) | PGⅡ/(ng/mL) | PGR |
---|---|---|---|---|
18~44岁组 | ||||
男性 | 936 | 57.70(47.08~71.73) | 13.25(9.18~21.43) | 4.83(2.99~5.85) |
女性 | 532 | 43.50(38.35~54.35)△ | 8.50(6.75~14.75)△ | 5.22(3.98~6.08)△ |
45~59岁组 | ||||
男性 | 724 | 67.30(53.75~86.25)* | 15.10(10.30~26.15)* | 4.57(2.71~6.09) |
女性 | 436 | 58.70(47.60~76.35)*△ | 12.10(9.30~20.20)*△ | 4.66(3.56~5.73) |
>59岁组 | ||||
男性 | 144 | 69.60(58.53~94.33)*# | 16.70(13.90~23.85)*# | 4.18(3.46~5.29) |
女性 | 108 | 57.35(51.95~77.20)*# | 11.35(9.80~22.30)*#△ | 4.84(4.21~5.89) |
组别 | PGⅠ/ (ng/mL) | PGⅡ/ (ng/mL) | PGR |
---|---|---|---|
男性 | 2.46~8.11 | ||
18~44岁 | 34.19~77.05 | 5.19~21.92 | |
45~59岁 | 26.81~143.10 | 5.60~46.60 | |
>59岁 | 53.20~151.80 | 8.50~30.40 | |
女性 | 2.45~8.73 | ||
18~44岁 | 26.44~89.26 | 4.21~27.14 | |
45~59岁 | 25.00~135.11 | 4.90~32.80 | |
>59岁 | 43.50~165.30 | 5.50~23.20 |
组别 | PGⅠ/ (ng/mL) | PGⅡ/ (ng/mL) | PGR |
---|---|---|---|
男性 | 2.46~8.11 | ||
18~44岁 | 34.19~77.05 | 5.19~21.92 | |
45~59岁 | 26.81~143.10 | 5.60~46.60 | |
>59岁 | 53.20~151.80 | 8.50~30.40 | |
女性 | 2.45~8.73 | ||
18~44岁 | 26.44~89.26 | 4.21~27.14 | |
45~59岁 | 25.00~135.11 | 4.90~32.80 | |
>59岁 | 43.50~165.30 | 5.50~23.20 |
[1] | 中华医学会消化病学分会. 中国慢性胃炎共识意见(2017年,上海)[J]. 胃肠病学, 2017, 22(11):670-687. |
[2] |
BANG C S, LEE J J, BAIK G H. Prediction of chronic atrophic gastritis and gastric neoplasms by serum pepsinogen assay:a systematic review and meta-analysis of diagnostic test accuracy[J]. J Clin Med, 2019, 8(5):657.
DOI URL |
[3] | 李俊, 姚保栋, 李为希, 等. 血清幽门螺杆菌抗体、胃蛋白酶原、胃泌素-17检测对5 552名社区胃癌高危人群的筛查研究[J]. 中国肿瘤, 2019, 28(8):629-635. |
[4] |
KUNZMANN A T, MCMENAMIN Ú C, SPENCE A D, et al. Blood biomarkers for early diagnosis of oesophageal cancer:a systematic review[J]. Eur J Gastroenterol Hepatol, 2018, 30(3):263-273.
DOI URL |
[5] |
CHIANG T H, CHIU S Y, CHEN S L, et al. Serum pepsinogen as a predictor for gastric cancer death:a 16-year community-based cobort study[J]. J Clin Gastroenterol, 2019, 53(5):e186-e193.
DOI URL |
[6] | 王洪亚, 张捷. 建立检验项目参考区间的探讨[J]. 临床检验杂志, 2011, 29(7):548-550. |
[7] | 殷明刚, 余建洪. 自贡地区血清肾功检验项目参考区间的建立及分析[J]. 四川医学, 2016, 37(3):277-280. |
[8] | Clinical and Laboratory Standards Institute,International Federation of Clinical Chemistry and Laboratory Medicine. Defining,establishing,and verifying the reference intervals in a clinical laboratory[S]. C28-A3,CLSI, 2012. |
[9] | 曹毛毛, 陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床, 2019, 46(3):145-149. |
[10] |
SAMLOFF I M, VARIS K, IHAMAKI T, et al. Relationships among serum pepsinogen Ⅰ,serum pepsinogen Ⅱ,and gastric mucosal histology. A study in relatives of patients with pernicious anemia[J]. Gastroenterology, 1982, 83(1 Pt 2):204-209.
DOI URL |
[11] |
GANTUYA B, OYUNTSETSEG K, BOLOR D, et al. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area[J]. Gastric Cancer, 2019, 22(1):104-112.
DOI URL |
[12] | 林蔚, 陈泽恒. 3 560例健康体检人群血清胃蛋白酶原检测结果分析[J]. 吉林医学, 2015, 36(14):3040-3041. |
[13] | 巍伟华, 丘创华, 黄文瑶, 等. 实验室血清胃蛋白酶原健康人群参考区间初步探讨[J]. 新疆医学, 2018, 48(2):164-166. |
[14] | 宋强, 高芳, 董文杰, 等. 包头汉族人群幽门螺杆菌感染状况调查[J]. 包头医学院学报, 2019, 35(1):1-2. |
[15] |
RAZUKA-EBELA D, POLAKA I, PARSHUTIN S, et al. Sociodemographic,lifestyle and medical factors associated with Helicobacter pylori infection[J]. J Gastrointestin Liver Dis, 2020, 29(3):319-327.
DOI URL |
[16] |
OKUDA M, LIN Y, MABE K, et al. Serum pepsinogen values in Japanese junior high school students with reference to Helicobacter pylori infection[J]. J Epidemiol, 2020, 30(1):30-36.
DOI URL |
[17] | 杨玉梅, 刘玉萍, 王林, 等. 成都地区居民幽门螺杆菌感染现状及危险因素分析[J]. 现代预防医学, 2020, 47(17):3220-3224. |
[18] |
KIKUCHI S, KATO M, MABE K, et al. Optimal criteria and diagnostic ability of serum pepsinogen values for Helicobacter pylori infection[J]. J Epidemiol, 2019, 29(4):147-154.
DOI URL |
[19] | 方香玉, 许程洁, 罗萍. 不同因素对血清胃蛋白酶原的影响及其参考区间差异分析[J]. 广东医学, 2016, 37(24):3683-3686. |
[1] | AN Yinghong, YAO Kechun, SU Chengming, TANG Jinhua, YANG Lixin, GAO Jie, XU Yanting, YAN Qiuhong, ZHAN Hongyan, MA Yueyun. Survey of serum homocysteine levels of apparently healthy subjects in Beijing [J]. Laboratory Medicine, 2023, 38(11): 1036-1040. |
[2] | ZHAO Yanhong, FU Lin, LIU Biao, XIAO Meifang. Reference interval of lactate dehydrogenase among 3-14-year-old population in Hainan [J]. Laboratory Medicine, 2023, 38(11): 1041-1043. |
[3] | XU Qianqian, JIANG Wangqing, SHEN Linjie, LU Yingjie, CHEN Jian, JIANG Haoqin. Establishment of the reference intervals for related parameters of adult reticulocytes in Shanghai [J]. Laboratory Medicine, 2022, 37(7): 641-645. |
[4] | MIAO Linzi, LU Yao, QU Chenxue, YOU Ran, GONG Yan. Establishment of the reference intervals of leukocyte surface CD64 and HLA-DR indexes for healthy adults and related factors [J]. Laboratory Medicine, 2022, 37(3): 240-245. |
[5] | LU Youli, YANG Shuangshuang, ZHANG Meiwei, OU Meixian, DONG Chunxia, SHEN Weiwei, JIANG Fengli, LI Shuijun. Simultaneous determination of 5 steroid hormones in human serum by ultra-performance liquid chromatography-tandem mass spectrometry and establishment of reference intervals in healthy adults [J]. Laboratory Medicine, 2022, 37(2): 165-173. |
[6] | LI Jing, QUAN Hui, ZENG Zhirong, WEI Yi. Establishment of the reference interval of small and dense low-density lipoprotein cholesterol in apparently healthy adults in Chengdu [J]. Laboratory Medicine, 2021, 36(6): 609-614. |
[7] | WANG Zipeng, OUYANG Changli, GENG Deqin, WANG Dunjing. Establishment of cerebrospinal fluid IL-6 reference interval in non-inflammatory central nervous system diseases [J]. Laboratory Medicine, 2021, 36(6): 627-630. |
[8] | YUE Bo, LI Danjie, TANG Dahai, LIU Manjiao, HE Jialei, JIANG Mengjie, WEI Xiaoqiang. Establishment of a new algorithm for the reference interval of relative change values and application evaluation [J]. Laboratory Medicine, 2021, 36(6): 667-673. |
[9] | JI Zhi, DENG Lingyan, LI Jiaoyuan, WANG Xu, LI Huijun, CHENG Liming. Reference interval establishment of serum cytokeratin 19 fragment for healthy adults in Wuhan [J]. Laboratory Medicine, 2021, 36(5): 490-494. |
[10] | ZOU Ning, CHEN Guangxi, MA Hua, Qiurang, Zhaxinamo. Survey on the reference intervals of venous blood cells among native Tibetan adults in Aba county [J]. Laboratory Medicine, 2021, 36(2): 198-201. |
[11] | AN Chongwen, LI Haixia, JIAO Lili. Establishment of reference interval for the detection of serum protein electrophoresis by V8 Nexus high speed automated capillary electrophoresis apparatus [J]. Laboratory Medicine, 2021, 36(1): 8-12. |
[12] | YUE Chaoyan, DUAN Chaohui, ZHANG Di, WEI Jie, LUO Xiaohong, ZHANG Qianlan, WU Yong, YING Chunmei. Performance evaluation of acridinium ester labeled direct chemiluminescence method for the detection of AMH and establishment of adult female AMH reference interval [J]. Laboratory Medicine, 2021, 36(1): 95-100. |
[13] | WU Qun, SHEN Junfei, WU Wenhao, WANG Beili, PAN Baishen, GUO Wei. Establishment of reference intervals of total bilirubin and direct bilirubin by indirect method [J]. Laboratory Medicine, 2020, 35(8): 749-752. |
[14] | DU Yuxuan, WANG Wei, HE Falin, ZHONG Kun, YUAN Shuai, LIU Jiali, ZHANG Zhixin, WANG Zhiguo. Investigation and analysis on pediatric reference intervals of routine chemistry items in China [J]. Laboratory Medicine, 2020, 35(7): 676-681. |
[15] | ZHANG Li, GE Liang, ZHANG Lanfang, MA Xiaoli, SUN Linchun. Establishment of reference interval of human leukocyte antigen-B27 in apparent healthy children [J]. Laboratory Medicine, 2020, 35(7): 695-698. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||